CVE intelligence and bounded remediation

CVE-2023-31923 — Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions

High CVSS 8.8

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

Severity
High
CVSS
8.8 (3.1)
Published
2023-05-22
CISA KEV
Not currently listed
Ecosystem
software/application
Weaknesses
CWE-281

Affected products

  • supremainc / biostar_2

Matched remediation archetype

General vulnerability remediation

This catalog composition supplies bounded fallback guidance. Explicitly reviewed curated workflows load with the complete record below.

Check exposure

  • Confirm the affected component, deployment paths, reachable interfaces, and enabled features from inventories and configuration, without probing production destructively.
  • Compare the advisory's affected conditions with the repository lockfiles, build manifests, artifacts, and runtime inventory.
  • Identify data sensitivity, trust boundaries, and privilege level for every confirmed affected deployment.

Remediate safely

  • Apply a vendor-supported fix or remove the affected component or feature; record the selected change and its source in the repository.
  • Update direct and transitive dependency locks, generated artifacts, deployment manifests, and asset inventories together.
  • Add a regression test for the documented unsafe condition using inert inputs and preserve rollback instructions.

Authoritative sources

Complete CVE record and remediation plan

The detailed catalog view below loads this exact record, its source evidence, and the full seven-phase agentic change plan.